TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS

Angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARB) slow down progression of cardiovascular diseases and reduce risk of mortality and life threatening complications. What it is better to prescribe for patient in a concrete clinical case - ACE inhibitors or ARB?...

Full description

Saved in:
Bibliographic Details
Main Authors: L. N. Malay (Author), A. N. Miroshnichenko (Author), B. V. Sharykin (Author), V. V. Konurovsky (Author)
Format: Book
Published: Столичная издательская компания, 2016-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_2bc9a1d3fe8e4af1bb5f13ce8347dc73
042 |a dc 
100 1 0 |a L. N. Malay  |e author 
700 1 0 |a A. N. Miroshnichenko  |e author 
700 1 0 |a B. V. Sharykin  |e author 
700 1 0 |a V. V. Konurovsky  |e author 
245 0 0 |a TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS 
260 |b Столичная издательская компания,   |c 2016-01-01T00:00:00Z. 
500 |a 1819-6446 
500 |a 2225-3653 
500 |a 10.20996/1819-6446-2009-5-4-85-92 
520 |a Angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARB) slow down progression of cardiovascular diseases and reduce risk of mortality and life threatening complications. What it is better to prescribe for patient in a concrete clinical case - ACE inhibitors or ARB? Authors compare these drug classes (mechanism of action, indications, evidense base of clinical trails, treatment costs and safety). The place of ACE inhibitors and ARB in modern therapy of cardiovascular diseases is defined. Results of the recent trails (ONTARGET, TRANCEND, PRoFESS, I-PRESERVE) are discussed. 
546 |a EN 
546 |a RU 
690 |a angiotensin converting enzyme inhibitors 
690 |a angiotensin ii receptor blockers 
690 |a cardiovascular diseases 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
690 |a Diseases of the circulatory (Cardiovascular) system 
690 |a RC666-701 
655 7 |a article  |2 local 
786 0 |n Рациональная фармакотерапия в кардиологии, Vol 5, Iss 4, Pp 85-92 (2016) 
787 0 |n https://www.rpcardio.online/jour/article/view/694 
787 0 |n https://doaj.org/toc/1819-6446 
787 0 |n https://doaj.org/toc/2225-3653 
856 4 1 |u https://doaj.org/article/2bc9a1d3fe8e4af1bb5f13ce8347dc73  |z Connect to this object online.